View of EFFICACY AND RISKS PROFILES OF “GLP-1 RECEPTOR AGONISTS” IN TYPE 2 DIABETES AND OBESITY: A SYSTEMATIC REVIEW OF BENEFITS AND RISKS

Return to Article Details EFFICACY AND RISKS PROFILES OF “GLP-1 RECEPTOR AGONISTS” IN TYPE 2 DIABETES AND OBESITY: A SYSTEMATIC REVIEW OF BENEFITS AND RISKS Download Download PDF